{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:23:47Z","timestamp":1707524627496},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,29]]},"DOI":"10.7759\/cureus.24609","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T23:29:06Z","timestamp":1651274946000},"source":"Crossref","is-referenced-by-count":0,"title":["Supraventricular Tachycardia Ablation and Its Effects on Anxiety Medications"],"prefix":"10.7759","author":[{"given":"Mohamed","family":"Mahmoud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Haloot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khadija","family":"El Kortbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Rodriguez Fuenmayor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mubeen","family":"Cheema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Auroa","family":"Badin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.08.856","article-title":"2015 ACC\/AHA\/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"67","author":"Page RL","year":"2016","unstructured":"Page RL, Joglar JA, Caldwell MA, et al.. 2015 ACC\/AHA\/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2016, 67:e27-e115. 10.1016\/j.jacc.2015.08.856","journal-title":"J Am Coll Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(97)00422-1","article-title":"Paroxysmal supraventricular tachycardia in the general population","volume":"31","author":"Orejarena LA","year":"1998","unstructured":"Orejarena LA, Vidaillet H Jr, DeStefano F, Nordstrom DL, Vierkant RA, Smith PN, Hayes JJ. Paroxysmal supraventricular tachycardia in the general population. J Am Coll Cardiol. 1998, 31:150-7. 10.1016\/s0735-1097(97)00422-1","journal-title":"J Am Coll Cardiol"},{"key":"ref3","article-title":"Evaluation of psychopathology in patients with paroxysmal supraventricular tachycardia","volume":"12","author":"Kitzlerov\u00e1 E","year":"2007","unstructured":"Kitzlerov\u00e1 E, Anders M, Kautzner J, Dohnalov\u00e1 A. Evaluation of psychopathology in patients with paroxysmal supraventricular tachycardia. Exp Clin Cardiol. 2007, 12:42-5.","journal-title":"Exp Clin Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2009.08.008","article-title":"Interoceptive sensitivity in anxiety and anxiety disorders: an overview and integration of neurobiological findings","volume":"30","author":"Domschke K","year":"2010","unstructured":"Domschke K, Stevens S, Pfleiderer B, Gerlach AL. Interoceptive sensitivity in anxiety and anxiety disorders: an overview and integration of neurobiological findings. Clin Psychol Rev. 2010, 30:1-11. 10.1016\/j.cpr.2009.08.008","journal-title":"Clin Psychol Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0887-6185(01)00080-9","article-title":"Heartbeat awareness and heart rate reactivity in anxiety sensitivity: a further investigation","volume":"15","author":"Stewart SH","year":"2001","unstructured":"Stewart SH, Buffett-Jerrott SE, Kokaram R. Heartbeat awareness and heart rate reactivity in anxiety sensitivity: a further investigation. J Anxiety Disord. 2001, 15:535-53. 10.1016\/s0887-6185(01)00080-9","journal-title":"J Anxiety Disord"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1997.00440260085013","article-title":"Unrecognized paroxysmal supraventricular tachycardia. Potential for misdiagnosis as panic disorder","volume":"157","author":"Lessmeier TJ","year":"1997","unstructured":"Lessmeier TJ, Gamperling D, Johnson-Liddon V, Fromm BS, Steinman RT, Meissner MD, Lehmann MH. Unrecognized paroxysmal supraventricular tachycardia. Potential for misdiagnosis as panic disorder. Arch Intern Med. 1997, 157:537-43. 10.1001\/archinte.1997.00440260085013","journal-title":"Arch Intern Med"},{"key":"ref7","article-title":"Influence of catheter ablation of paroxysmal supraventricular tachycardia on patients\u2019 anxiety","author":"Papiashvili G","year":"2018","unstructured":"Papiashvili G, Tabagari-Bregvadze N, Brugada J. Influence of catheter ablation of paroxysmal supraventricular tachycardia on patients\u2019 anxiety. Georgian Med News. 2018, 58-60.","journal-title":"Georgian Med News"},{"key":"ref8","article-title":"The effect of radiofrequency ablation treatment on quality of life and anxiety in patients with supraventricular tachycardia","volume":"16","author":"Yildirim O","year":"2012","unstructured":"Yildirim O, Yontar OC, Semiz M, Erdem A, Canan F, Yontar G, Ku\u011fu N. The effect of radiofrequency ablation treatment on quality of life and anxiety in patients with supraventricular tachycardia. Eur Rev Med Pharmacol Sci. 2012, 16:2108-12.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/1744-859X-9-13","article-title":"Coincidence of paroxysmal supraventricular tachycardia and panic disorder: two case reports","volume":"9","author":"Domschke K","year":"2010","unstructured":"Domschke K, Kirchhof P, Zwanzger P, Gerlach AL, Breithardt G, Deckert J. Coincidence of paroxysmal supraventricular tachycardia and panic disorder: two case reports. Ann Gen Psychiatry. 2010, 9:13. 10.1186\/1744-859X-9-13","journal-title":"Ann Gen Psychiatry"},{"key":"ref10","article-title":"Impact of radiofrequency catheter ablation on health-related quality of life assessed by the SF-36 questionnaire in patients with paroxysmal supraventricular tachycardia","author":"Papiashvili G","year":"2018","unstructured":"Papiashvili G, Tabagari-Bregvadze N, Brugada J. Impact of radiofrequency catheter ablation on health-related quality of life assessed by the SF-36 questionnaire in patients with paroxysmal supraventricular tachycardia. Georgian Med News. 2018, 54-7.","journal-title":"Georgian Med News"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","article-title":"Diagnostic and statistical manual of mental disorders, Fifth Edition","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders, Fifth Edition. American Psychiatric Publishing, Arlington; 2013. 10.1176\/appi.books.9780890425596"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2009.04.040","article-title":"Meta-analysis of ablation of atrial flutter and supraventricular tachycardia","volume":"104","author":"Spector P","year":"2009","unstructured":"Spector P, Reynolds MR, Calkins H, et al.. Meta-analysis of ablation of atrial flutter and supraventricular tachycardia. Am J Cardiol. 2009, 104:671-7. 10.1016\/j.amjcard.2009.04.040","journal-title":"Am J Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.99.2.262","article-title":"Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators Group","volume":"99","author":"Calkins H","year":"1999","unstructured":"Calkins H, Yong P, Miller JM, et al.. Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators Group. Circulation. 1999, 99:262-70. 10.1161\/01.cir.99.2.262","journal-title":"Circulation"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.6.28","article-title":"Sustained high quality of life in a 5-year long term follow-up after successful ablation for supra-ventricular tachycardia. Results from a large retrospective patient cohort","volume":"6","author":"Meissner A","year":"2009","unstructured":"Meissner A, Stifoudi I, Weism\u00fcller P, et al.. Sustained high quality of life in a 5-year long term follow-up after successful ablation for supra-ventricular tachycardia. Results from a large retrospective patient cohort. Int J Med Sci. 2009, 6:28-36. 10.7150\/ijms.6.28","journal-title":"Int J Med Sci"},{"key":"ref15","article-title":"[Long-term outcome of catheter ablation therapy of supraventricular tachyarrhythmias]","volume":"57","author":"Par\u00edzek P","year":"2011","unstructured":"Par\u00edzek P, Haman L, Dost\u00e1lov\u00e1 H, Duda J, Popelka J. [Long-term outcome of catheter ablation therapy of supraventricular tachyarrhythmias]. Vnitr Lek. 2011, 57:546-50.","journal-title":"Vnitr Lek"},{"key":"ref16","article-title":"Review of economic evaluations of radiofrequency catheter ablation for cardiac arrhythmias","volume":"19","author":"Marshall DA","year":"2003","unstructured":"Marshall DA, O'Brien BJ, Nichol G. Review of economic evaluations of radiofrequency catheter ablation for cardiac arrhythmias. Can J Cardiol. 2003, 19:1285-304.","journal-title":"Can J Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-133-11-200012050-00010","article-title":"Cost-effectiveness of radiofrequency ablation for supraventricular tachycardia","volume":"133","author":"Cheng CH","year":"2000","unstructured":"Cheng CH, Sanders GD, Hlatky MA, et al.. Cost-effectiveness of radiofrequency ablation for supraventricular tachycardia. Ann Intern Med. 2000, 133:864-76. 10.7326\/0003-4819-133-11-200012050-00010","journal-title":"Ann Intern Med"},{"key":"ref18","article-title":"Cost-effectiveness of radiofrequency ablation compared with other strategies in Wolff-Parkinson-White syndrome","volume":"88","author":"Hogenhuis W","year":"1993","unstructured":"Hogenhuis W, Stevens SK, Wang P, Wong JB, Manolis AS, Estes NA 3rd, Pauker SG. Cost-effectiveness of radiofrequency ablation compared with other strategies in Wolff-Parkinson-White syndrome. Circulation. 1993, 88:II437-46.","journal-title":"Circulation"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/heart.86.2.167","article-title":"Symptomatic improvement after radiofrequency catheter ablation for typical atrial flutter","volume":"86","author":"O'Callaghan PA","year":"2001","unstructured":"O'Callaghan PA, Meara M, Kongsgaard E, et al.. Symptomatic improvement after radiofrequency catheter ablation for typical atrial flutter. Heart. 2001, 86:167-71. 10.1136\/heart.86.2.167","journal-title":"Heart"},{"key":"ref20","article-title":"WHOQOL-BREF: Introduction, Administration, Scoring and Generic Version of the Assessment: Field Trial Version","year":"1996","unstructured":"WHOQOL-BREF. Introduction, Administration, Scoring and Generic Version of the Assessment: Field Trial Version. World Health Organization,  Geneva; 1996."},{"key":"ref21","article-title":"Manual for the State-Trait Anxiety Inventory","author":"Spielberger CD","year":"1983","unstructured":"Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA . Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press, Palo Alto; 1983."},{"key":"ref22","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware JE Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992, 30:473-83.","journal-title":"Med Care"},{"key":"ref23","article-title":"Practice guideline for the treatment of patients with panic disorder","volume":"155","author":"American Psychiatric Assn Work Group on Panic Disorder","year":"1998","unstructured":"American Psychiatric Assn Work Group on Panic Disorder, American Psychiatric Assn Steering Committee on Practice Guidelines. Practice guideline for the treatment of patients with panic disorder. Am J Psychiatry. 1998, 155:1-34.","journal-title":"Am J Psychiatry"},{"key":"ref24","article-title":"National Institute for Health and Care Excellence. Generalised anxiety disorder and panic disorder in adults: management","author":"National Institute for Health and Care Excellence","year":"2011","unstructured":"National Institute for Health and Care Excellence. Generalised Anxiety Disorder and Panic Disorder (With or Without Agoraphobia) In Adults: Management in Primary, Secondary and Community Care. NICE, London; 2011. https:\/\/www.nice.org.uk\/guidance\/cg113."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e7500","article-title":"Generalized anxiety disorder: diagnosis and treatment","volume":"345","author":"Hoge EA","year":"2012","unstructured":"Hoge EA, Ivkovic A, Fricchione GL. Generalized anxiety disorder: diagnosis and treatment. BMJ. 2012, 345:e7500. 10.1136\/bmj.e7500","journal-title":"BMJ"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008120.pub2","article-title":"Second-generation antipsychotics for anxiety disorders","author":"Depping AM","year":"2010","unstructured":"Depping AM, Komossa K, Kissling W, Leucht S. Second-generation antipsychotics for anxiety disorders. Cochrane Database Syst Rev. 2010, CD008120. 10.1002\/14651858.CD008120.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2015.17.3\/akaczkurkin","article-title":"Cognitive-behavioral therapy for anxiety disorders: an update on the empirical evidence","volume":"17","author":"Kaczkurkin AN","year":"2015","unstructured":"Kaczkurkin AN, Foa EB. Cognitive-behavioral therapy for anxiety disorders: an update on the empirical evidence. Dialogues Clin Neurosci. 2015, 17:337-46. 10.31887\/DCNS.2015.17.3\/akaczkurkin","journal-title":"Dialogues Clin Neurosci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/95763-supraventricular-tachycardia-ablation-and-its-effects-on-anxiety-medications","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:39:06Z","timestamp":1707507546000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/95763-supraventricular-tachycardia-ablation-and-its-effects-on-anxiety-medications"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,29]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.24609","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,29]]}}}